682.38MMarket Cap-2034P/E (TTM)
6.590High6.540Low10.52MVolume6.580Open6.560Pre Close69.03MTurnover12.62%Turnover RatioLossP/E (Static)104.18MShares16.98052wk High-5.26P/B546.14MFloat Cap2.30052wk Low--Dividend TTM83.38MShs Float42.410Historical High--Div YieldTTM0.76%Amplitude2.300Historical Low6.558Avg Price1Lot Size
Revance Therapeutics Stock Forum
Crown Laboratories and Revance Announce Entry Into Merger Agreement
Crown Laboratories and Revance Therapeutics (NASDAQ: RVNC) have announced a merger agreement, with Crown offering to acquire all outstanding Revance shares for $6.66 per share in cash. This represents a total enterprise value of $924 million and a 89% premium over Revance's closing price on August 9, 2024. The merger aims to create a leading, innovative aesthetics and skincare company, combini...
No comment yet